Reviva Pharmaceuticals Holdings, Inc.
NASDAQ:RVPH

  • LAST PRICE
    0.9985
  • TODAY'S CHANGE (%)
    0.0000 (0.0000%)
  • Bid / Lots
    0.9940/ 82
  • Ask / Lots
    1.2300/ 1
  • Open / Previous Close
    --- / 0.9985
  • Day Range
    ---
  • 52 Week Range
    0.6000
    6.3001
  • Volume
    20

Search Criteria

Click on magnifying glass icon to search

CompanyCountrySymbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

  • Oct 31, 2024

      Show headlines and story abstract

    • 8:00AM ET on Thursday Oct 31, 2024 by Dow Jones
      Companies Mentioned: RVPH

      Reviva to Participate in the UBS Global Healthcare Conference

      CUPERTINO, Calif., Oct. 31, 2024 (GLOBE NEWSWIRE) -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) ("Reviva" or the "Company"), a late-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of central nervous system (CNS), inflammatory and cardiometabolic diseases, today announced that Laxminarayan Bhat, Ph.D., Founder, President, and CEO of Reviva will participate in a fireside chat at the UBS Global Healthcare Conference, taking place November 11-14, 2024, in Rancho Palos Verdes, CA.

  • Oct 8, 2024

      Show headlines and story abstract

    • 8:00AM ET on Tuesday Oct 08, 2024 by Dow Jones
      Companies Mentioned: RVPH

      Reviva to Participate in the 2024 Maxim Healthcare Virtual Summit

      CUPERTINO, Calif., Oct. 08, 2024 (GLOBE NEWSWIRE) -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) ("Reviva" or the "Company"), a late-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of central nervous system (CNS), inflammatory and cardiometabolic diseases, today announced that Laxminarayan Bhat, Ph.D., Founder, President, and CEO of Reviva will participate in a fireside chat at the 2024 Maxim Healthcare Virtual Summit, taking place virtually October 15-17, 2024.

Peers Headlines